The use of Roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease

Joseph Murphy, R. Scott Wright, Ihor Gussak, Brent Williams, Robert N. Daly, Valerie A. Cain, Henry J. Pieniaszek, Sherwin K.B. Sy, William Ebling, Kristen Simonson, Racehl A. Wilcox, Stephen L. Kopecky

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'The use of Roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease'. Together they form a unique fingerprint.

Medicine & Life Sciences